Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration
- 1 February 2015
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 36 (2) , 608-617
Abstract
No abstract availableKeywords
Funding Information
- BrightFocus Foundation (grant number A2011310)
- NIH (NS050537))
- Litwin Foundation
- May and Samuel Rudin Family Foundation
- Blanchette Hooker Rockefeller Fund
- Mellam Family Foundation
- PHS (R24 MH068855))
This publication has 63 references indexed in Scilit:
- Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrinBlood, 2012
- Alzheimer Mechanisms and Therapeutic StrategiesCell, 2012
- Plasma Biomarkers of Brain Atrophy in Alzheimer's DiseasePLOS ONE, 2011
- Multicolor time-stamp reveals the dynamics and toxicity of amyloid depositionScientific Reports, 2011
- Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?Experimental Gerontology, 2011
- Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerizationProceedings of the National Academy of Sciences, 2010
- The overlap between neurodegenerative and vascular factors in the pathogenesis of dementiaActa Neuropathologica, 2010
- Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's DiseaseNeuron, 2010
- Alzheimer disease models and human neuropathology: similarities and differencesActa Neuropathologica, 2007
- Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's diseaseJournal of Experimental Medicine, 2007